Press release
Gastric Cancer Market Assessment (2022-32) | Key Insights Into the Market Share, Epidemiology and the Patient Population, Treatment Practices, Emerging Therapies, and Prominent Companies Involved
Gastric Cancer Market
DelveInsight's "Gastric Cancer Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Gastric Cancer Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Gastric Cancer market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.
Gastric Cancer: An Overview
Gastric Cancer (GC), also called Stomach Cancer, is a heterogeneous disease that demands continued attention and research concerning prevention, early detection, and novel therapeutic options. The global distribution of GC varies substantially across geographical regions, which illustrates the multitude of factors that are associated with the incidence, survival, and mortality of the disease. As per the American Cancer Society, in the United States, an estimated 27,600 cases of Gastric Cancer were supposed to be diagnosed in 2020.
There are many known risk factors for GC, but it is not known precisely how these factors cause cells of the stomach lining to become cancerous; this is the subject of ongoing research.
According to DelveInsight, the expected launch of pipeline therapies like RC48 (RemeGen), BOLD-100 (Bold Therapeutics), IBI308 (Innovent Biologics), and others will signigicantly spur market growth in the coming years.
Gastric Cancer Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Gastric Cancer market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives complete detail of the Gastric Cancer market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Discover How Gastric Cancer Market will Grow by 2032:
https://www.delveinsight.com/report-store/gastric-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Gastric Cancer Epidemiology
The epidemiology section covers detailed insights into the historical and current Gastric Cancer patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.
The Report Covers the Gastric Cancer Epidemiology Segmented by -
• Total Incident Cases of Gastric Cancer
• Age-specific Incidence of Gastric Cancer
• Gender-specific Incidence of Gastric Cancer
• Stage-specific Incidence of Gastric Cancer
• Diagnosed and Treatable Cases of Gastric Cancer
• Cases of Gastric Cancer associated with HER2 Overexpression
Get Key Insights Into the Evolving Gastric Cancer Epidemiology Trends:
https://www.delveinsight.com/report-store/gastric-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Gastric Cancer Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastric Cancer market or expected to get launched in the market during the study period. The analysis covers the Gastric Cancer market uptake by drugs, patient uptake by therapies, and sales of each drug.
Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake and reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Gastric Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Gastric Cancer Therapeutics Assessment
As per DelveInsight, the dynamics of the Gastric Cancer (GC) market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of emerging therapies.
Some of the key companies in the Gastric Cancer therapeutics market include
• RemeGen
• Innovent Biologics
• Bold Therapeutics
• MacroGenics
• Transcenta
And many others
Gastric Cancer therapies covered in the report include
• RC48
• IBI308
• BOLD-100
• Margetuximab
• TST001
And many more
With the development and the launch of emerging therapies, it would be safe to assume that the market size for gastric cancer shall experience a positive boost in the upcoming years.
Learn More About the Emerging Therapies & Key Companies in the Gastric Cancer Therapeutics Market:
https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Gastric Cancer Competitive Intelligence Analysis
4. Gastric Cancer Market Overview at a Glance
5. Gastric Cancer Disease Background and Overview
6. Gastric Cancer Patient Journey
7. Gastric Cancer Epidemiology and Patient Population
8. Gastric Cancer Treatment Algorithm, Current Treatment, and Medical Practices
9. Gastric Cancer Unmet Needs
10. Key Endpoints of Gastric Cancer Treatment
11. Gastric Cancer Marketed Products
12. Gastric Cancer Emerging Therapies
13. Gastric Cancer Seven Major Market Analysis
14. Attribute Analysis
15. Gastric Cancer Market Outlook (7 major markets)
16. Gastric Cancer Access and Reimbursement Overview
17. KOL Views on the Gastric Cancer Market.
18. Gastric Cancer Market Drivers
19. Gastric Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Download the Sample PDF to Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/gastric-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastric Cancer Market Assessment (2022-32) | Key Insights Into the Market Share, Epidemiology and the Patient Population, Treatment Practices, Emerging Therapies, and Prominent Companies Involved here
News-ID: 2808747 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
